Discover 999 paid clinical trials in Rochester, Minnesota. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 999
Gene Therapy for HER-Positive Cancer (SENTRY-HER2)
Get alerts for new trials in your area by subscribing now
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia
Location: Rochester MN, La Crosse WI, Burnsville MN, Woodbury MN,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 65+
Code: NCT07321652
Phase 3, Recruiting
Safety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematologic Autoimmune Disease
for
Warm Autoimmune Hemolytic Anemia (WAIHA),
Location: Rochester MN, Omaha NE, Boston MA
Sponsor: CRISPR Therapeutics AG
Sex: All
Age: 18+
Code: NCT07549698
Phase 1, Phase 2, Recruiting
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
for
Non-small Cell Lung Cancer
Location: Rochester MN, Hinsdale IL, Canton OH, Atlanta GA,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT06899126
Phase 3, Recruiting
Neoadjuvant Darovasertib in Primary Uveal Melanoma
for
Uveal Melanoma
Location: Rochester MN, Grand Rapids MI, Nashville TN, Toronto,
Sponsor: IDEAYA Biosciences
Sex: All
Age: 18+
Code: NCT07015190
Phase 3, Recruiting
Obstructive Sleep Apnea Among Somali-Americans
for
Obstructive Sleep Apnea
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT04124848
Recruiting
A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)
for
High Risk Smoldering Multiple Myeloma (HR-SMM)
Location: Rochester MN, St Louis MO, Detroit MI, Columbus OH,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07393282
Phase 3, Recruiting
Vasodilator Therapy With Isosorbide Mononitrate or Diltiazem to Reduce Vasotoxicity in Patients With Gastrointestinal Cancer Receiving Fluoropyrimidine Therapy
for
Malignant Digestive System Neoplasm
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT07456852
Phase 1, Phase 2, Recruiting
Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
for
Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC,
Location: Rochester MN, Chicago IL, Nashville TN, Atlanta GA,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT07621718
Phase 3, Recruiting
A Digital Treatment Platform for the Delivery of Home-Based Sequential Therapy in Patients With Glioma, GHoST Trial
for
Glioma, Recurrent Glioma, Recurrent Glioblastoma
Location: Rochester MN, Jacksonville FL
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT07074756
Recruiting
Evaluation of the Fully Closed Loop OmnipodĀ® System in Type 2 Diabetes
for
Type 2 Diabetes Mellitus
Location: Rochester MN, Minneapolis MN, Chicago IL,
Sponsor: Insulet Corporation
Sex: All
Age: 18 - 70+
Code: NCT07521475
Recruiting
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
for
Colon Adenocarcinoma, Rectal Adenocarcinoma
Location: Rochester MN, Iowa City IA, Milwaukee WI, Omaha NE,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06997497
Phase 3, Recruiting
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-011 in Patients With Advanced Solid Tumor
for
Advanced Liver Cancer
Location: Rochester MN, New York NY, Houston TX, Jacksonville FL,
Sponsor: Abbisko Therapeutics Co, Ltd
Sex: All
Age: 18 - 70+
Code: NCT04906434
Phase 1, Recruiting
Registry on NeVa VS for CerebraL VAsospasm ManagemenT in Post SAH PatiEnts